BERGEN BRUNSWIG CORP
8-K, 1998-11-12
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: CARLYLE INDUSTRIES INC, 10-Q, 1998-11-12
Next: BERKLEY W R CORP, 10-Q, 1998-11-12



================================================================================

                       SECURITIES AND EXCHANGE COMMISSION


                             WASHINGTON, D.C. 20549
                             ----------------------





                                    FORM 8-K


                                 CURRENT REPORT
                     PURSUANT TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934
                         -------------------------------




Date of Report (Date of earliest event reported):  November 9, 1998
                                                 ---------------------




                           BERGEN BRUNSWIG CORPORATION
- --------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)

  New Jersey                        1-5110                       22-1444512     
- ---------------                     ------                       ----------     
(State Or Other                  (Commission                   (IRS Employer    
Jurisdiction Of                  File Number)                Identification No.)
 Incorporation)




             4000 Metropolitan Drive, Orange, California 92868-3598
- --------------------------------------------------------------------------------
               (Address of Principal Executive Offices) (Zip Code)


Registrant's telephone number, including area code   (714) 385-4000
                                                  ------------------





================================================================================



<PAGE>


Item 5.  Other Events.



         On November 9, 1998, Bergen Brunswig Corporation ("BBC") entered into a
Stock  Purchase  Agreement  with  Stadtlander  Drug Co., Inc.  ("SDC"),  Counsel
Corporation  ("Counsel"),  Stadt Holdings Inc.  ("SHI",  and  collectively  with
Counsel,  the "Sellers") pursuant to which BBC has agreed to acquire 100% of the
outstanding  stock of SDC.  SDC is a leader in  disease-specific  pharmaceutical
care  delivery for  transplant,  HIV,  infertility  and serious  mental  illness
patient  populations.  SDC is also a leading provider of pharmaceutical  care to
the  privatized  corrections  market.  The estimated net purchase  price is $300
million,  together with the assumption of approximately $100 million in debt and
subject  to certain  adjustments.  In  addition,  BBC will pay the  Sellers  $28
million in  connection  with an election to treat this  transaction  as an asset
purchase for tax  purposes.  The purchase  price is payable one half in cash and
one half in BBC's  Class A Common  Stock,  subject to BBC's right to convert the
consideration  to "all cash" in the event that the market price of BBC's Class A
Common Stock falls below a specified level.

         The pending  acquisition  is subject to certain  conditions,  including
compliance with the requirements of the Hart-Scott-Rodino Antitrust Improvements
Act and the receipt of approval of Counsel's shareholders.  Certain of Counsel's
directors and related parties, owning approximately 23% of Counsel's outstanding
shares,  have  agreed  to vote  their  shares in favor of the  transaction.  The
transaction will be accounted for as a purchase.





<PAGE>


                                    SIGNATURE



                  Pursuant to the requirements of the Securities Exchange Act of
1934,  the  Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.



                           BERGEN BRUNSWIG CORPORATION




                             By: /s/ Milan A. Sawdei
                                ------------------------------------------
                                     Milan A. Sawdei
                                     Executive Vice President
                                     Chief Legal Officer and Secretary

Date:  November 12, 1998






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission